Norovirus infection in immunocompromised hosts

Clinical Microbiology and Infection

Volumn 20, Issue 8, 2014, Pages 717-723

  Green, K Y ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

Acquired immunodeficiency; Chronic infection; Immunocompromised; Immunosuppressed; Norovirus

Indexed keywords

ANTIVIRUS AGENT; VACCINE;

ACUTE GASTROENTERITIS; CHILDHOOD DISEASE; COHORT ANALYSIS; DISEASE CARRIER; DISEASE DURATION; EVOLUTION; GENETIC VARIABILITY; HOSPITAL INFECTION; HUMAN; IMMUNOCOMPROMISED PATIENT; INFECTION CONTROL; NONHUMAN; NOROVIRUS; NOROVIRUS INFECTION; PERSISTENT INFECTION; PRIORITY JOURNAL; REVIEW; RISK FACTOR; CALICIVIRUS INFECTION; GASTROENTERITIS; IMMUNOLOGY; ISOLATION AND PURIFICATION; PATHOLOGY; VIROLOGY;

CALICIVIRIDAE INFECTIONS; GASTROENTERITIS; HUMANS; IMMUNOCOMPROMISED HOST; NOROVIRUS;

EID: 84906515707     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/1469-0691.12761     Document Type: Review

References (73)

1. Gastanaduy PA, Hall AJ, Curns AT, Parashar UD, Lopman BA. Burden of norovirus gastroenteritis in the ambulatory setting-United States, 2001-2009. J Infect Dis 2013; 207: 1058-1065.
2. Hall AJ, Lopman BA, Payne DC et al. Norovirus disease in the United States. Emerg Infect Dis 2013; 19: 1198-1205.
3. Payne DC, Vinje J, Szilagyi PG et al. Norovirus and medically attended gastroenteritis in US children. N Engl J Med 2013; 368: 1121-1130.
4. Koo HL, Neill FH, Estes MK et al. Noroviruses: the most common pediatric viral enteric pathogen at a large university hospital after introduction of rotavirus vaccination. J Pediatric Infect Dis Soc 2013; 2: 57-60.
5. Atmar RL, Estes MK. Norovirus vaccine development: next steps. Expert Rev Vaccines 2012; 11: 1023-1025.
6. Bok K, Green KY. Norovirus gastroenteritis in immunocompromised patients. N Engl J Med 2012; 367: 2126-2132.
7. Atmar J, Mullen E. Norovirus in immunocompromised patients. Oncol Nurs Forum 2013; 40: 434-436.
8. Kaufman SS, Green KY, Korba BE. Treatment of norovirus infections: moving antivirals from the bench to the bedside. Antiviral Res 2014; 105C: 80-91.
9. Trivedi TK, Desai R, Hall AJ, Patel M, Parashar UD, Lopman BA. Clinical characteristics of norovirus-associated deaths: a systematic literature review. Am J Infect Control 2013; 41: 654-657.
10. Lew JF, Petric M, Kapikian AZ, Jiang X, Estes MK, Green KY. Identification of minireovirus as a Norwalk-like virus in pediatric patients with gastroenteritis. J Virol 1994; 68: 3391-3396.
11. Xerry J, Gallimore CI, Cubitt D, Gray JJ. Tracking environmental norovirus contamination in a pediatric primary immunodeficiency unit. J Clin Microbiol 2010; 48: 2552-2556.
12. Gallimore CI, Lewis D, Taylor C, Cant A, Gennery A, Gray JJ. Chronic excretion of a norovirus in a child with cartilage hair hypoplasia (CHH). J Clin Virol 2004; 30: 196-204.
13. Frange P, Touzot F, Debre M et al. Prevalence and clinical impact of norovirus fecal shedding in children with inherited immune deficiencies. J Infect Dis 2012; 206: 1269-1274.
14. Kaufman SS, Chatterjee NK, Fushino ME, et al. Calicivirus enteritis in an intestinal transplant recipient. Am J Transp 2003; 3: 764-768.
15. Chehade H, Girardin E, Delich V, Pascual MA, Venetz JP, Cachat F. Acute norovirus-induced agranulocytosis in a pediatric kidney transplant recipient. Transpl Infect Dis 2012; 14: E27-E29.
16. Saif MA, Bonney DK, Bigger B et al. Chronic norovirus infection in pediatric hematopoietic stem cell transplant recipients: a cause of prolonged intestinal failure requiring intensive nutritional support. Pediatr Transplant 2011; 15: 505-509.
17. Siebenga JJ, Beersma MF, Vennema H, van Biezen P, Hartwig NJ, Koopmans M. High prevalence of prolonged norovirus shedding and illness among hospitalized patients: a model for in vivo molecular evolution. J Infect Dis 2008; 198: 994-1001.
18. Simon A, Schildgen O, Maria Eis-Hubinger A et al. Norovirus outbreak in a pediatric oncology unit. Scand J Gastroenterol 2006; 41: 693-699.
19. Ludwig A, Adams O, Laws HJ, Schroten H, Tenenbaum T. Quantitative detection of norovirus excretion in pediatric patients with cancer and prolonged gastroenteritis and shedding of norovirus. J Med Virol 2008; 80: 1461-1467.
20. Salvador C, Meister B, Larcher H, Crazzolara R, Kropshofer G. Hemophagocytic lymphohistiocytosis after allogeneic bone marrow transplantation during chronic norovirus infection. Hematol Oncol 2014; 32: 102-106.
21. Kim MJ, Kim YJ, Lee JH et al. Norovirus: a possible cause of pneumatosis intestinalis. J Pediatr Gastroenterol Nutr 2011; 52: 314-318.
22. Robles JD, Cheuk DK, Ha SY, Chiang AK, Chan GC. Norovirus infection in pediatric hematopoietic stem cell transplantation recipients: incidence, risk factors, and outcome. Biol Blood Marrow Transplant 2012; 18: 1883-1889.
23. Munir N, Liu P, Gastanaduy P, Montes J, Shane A, Moe C. Norovirus infection in immunocompromised children and children with hospital-acquired acute gastroenteritis. J Med Virol 2014; 86: 1203-1209.
24. Roddie C, Paul JP, Benjamin R et al. Allogeneic hematopoietic stem cell transplantation and norovirus gastroenteritis: a previously unrecognized cause of morbidity. Clin Infect Dis 2009; 49: 1061-1068.
25. Boillat Blanco N, Kuonen R, Bellini C et al. Chronic norovirus gastroenteritis in a double hematopoietic stem cell and lung transplant recipient. Transpl Infect Dis 2011; 13: 213-215.
26. Doshi M, Woodwell S, Kelleher K, Mangan K, Axelrod P. An outbreak of norovirus infection in a bone marrow transplant unit. Am J Infect Control 2013; 41: 820-823.
27. Schwartz S, Vergoulidou M, Schreier E et al. Norovirus gastroenteritis causes severe and lethal complications after chemotherapy and hematopoietic stem cell transplantation. Blood 2011; 117: 5850-5856.
28. Westhoff TH, Vergoulidou M, Loddenkemper C et al. Chronic norovirus infection in renal transplant recipients. Nephrol Dial Transplant 2009; 24: 1051-1053.
29. Schorn R, Hohne M, Meerbach A et al. Chronic norovirus infection after kidney transplantation: molecular evidence for immune-driven viral evolution. Clin Infect Dis 2010; 51: 307-314.
30. Roos-Weil D, Ambert-Balay K, Lanternier F et al. Impact of norovirus/sapovirus-related diarrhea in renal transplant recipients hospitalized for diarrhea. Transplantation 2011; 92: 61-69.
31. Chagla Z, Quirt J, Woodward K, Neary J, Rutherford C. Chronic norovirus infection in a transplant patient successfully treated with enterally administered immune globulin. J Clin Virol 2013; 58: 306-308.
32. Nilsson M, Hedlund KO, Thorhagen M et al. Evolution of human calicivirus RNA in vivo: accumulation of mutations in the protruding P2 domain of the capsid leads to structural changes and possibly a new phenotype. J Virol 2003; 77: 13117-13124.
33. Wingfield T, Gallimore CI, Xerry J et al. Chronic norovirus infection in an HIV-positive patient with persistent diarrhoea: a novel cause. J Clin Virol 2010; 49: 219-222.
34. Siddiq DM, Koo HL, Adachi JA, Viola GM. Norovirus gastroenteritis successfully treated with nitazoxanide. J Infect 2011; 63: 394-397.
35. Crossley K, Peterson PK. Infections in the elderly-new developments. Curr Clin Top Infect Dis 1998; 18: 75-100.
36. van Asten L, Siebenga J, van den Wijngaard C et al. Unspecified gastroenteritis illness and deaths in the elderly associated with norovirus epidemics. Epidemiology 2011; 22: 336-343.
37. Trivedi TK, DeSalvo T, Lee L et al. Hospitalizations and mortality associated with norovirus outbreaks in nursing homes, 2009-2010. JAMA 2012; 308: 1668-1675.
38. Mattner F, Sohr D, Heim A, Gastmeier P, Vennema H, Koopmans M. Risk groups for clinical complications of norovirus infections: an outbreak investigation. Clin Microbiol Infect 2006; 12: 69-74.
39. Bresee JS, Marcus R, Venezia RA et al. The etiology of severe acute gastroenteritis among adults visiting emergency departments in the United States. J Infect Dis 2012; 205: 1374-1381.
40. Rhinehart E, Walker S, Murphy D, O'Reilly K, Leeman P. Frequency of outbreak investigations in US hospitals: results of a national survey of infection preventionists. Am J Infect Control 2012; 40: 2-8.
41. Sukhrie FH, Siebenga JJ, Beersma MF, Koopmans M. Chronic shedders as reservoir for nosocomial transmission of norovirus. J Clin Microbiol 2010; 48: 4303-4305.
42. Pedersen NC, Hawkins KF. Mechanisms for persistence of acute and chronic feline calicivirus infections in the face of vaccination. Vet Microbiol 1995; 47: 141-156.
43. Dick CP, Johnson RP, Yamashiro S. Sites of persistence of feline calicivirus. Res Vet Sci 1989; 47: 367-373.
44. Johnson RP. Antigenic change in feline calicivirus during persistent infection. Can J Vet Res 1992; 56: 326-330.
45. Wobus CE, Thackray LB, Virgin HW. Murine norovirus: a model system to study norovirus biology and pathogenesis. J Virol 2006; 80: 5104-5112.
46. Tomov VT, Osborne LC, Dolfi DV et al. Persistent enteric murine norovirus infection is associated with functionally suboptimal virus-specific CD8 T cell responses. J Virol 2013; 87: 7015-7031.
47. Arias A, Bailey D, Chaudhry Y, Goodfellow I. Development of a reverse-genetics system for murine norovirus 3: long-term persistence occurs in the caecum and colon. J Gen Virol 2012; 93 (Pt 7): 1432-1441.
48. Nice TJ, Strong DW, McCune BT, Pohl CS, Virgin HW. A single-amino-acid change in murine norovirus NS1/2 is sufficient for colonic tropism and persistence. J Virol 2013; 87: 327-334.
49. Pelizzo G, Nakib G, Goruppi I et al. Isolated colon ischemia with norovirus infection in preterm babies: a case series. J Med Case Rep 2013; 7: 108-111.
50. Ward JM, Wobus CE, Thackray LB et al. Pathology of immunodeficient mice with naturally occurring murine norovirus infection. Toxicol Pathol 2006; 34: 708-715.
51. Gallimore CI, Cubitt DW, Richards AF, Gray JJ. Diversity of enteric viruses detected in patients with gastroenteritis in a tertiary referral paediatric hospital. J Med Virol 2004; 73: 443-449.
52. Kundu S, Lockwood J, Depledge DP et al. Next-generation whole genome sequencing identifies the direction of norovirus transmission in linked patients. Clin Infect Dis 2013; 57: 407-414.
53. Sukhrie FH, Beersma MF, Wong A et al. Using molecular epidemiology to trace transmission of nosocomial norovirus infection. J Clin Microbiol 2011; 49: 602-606.
54. Bull RA, Eden JS, Luciani F, McElroy K, Rawlinson WD, White PA. Contribution of intra- and interhost dynamics to norovirus evolution. J Virol 2012; 86: 3219-3229.
55. Debbink K, Lindesmith LC, Ferris MT et al. Within host evolution results in antigenically distinct GII.4 noroviruses. J Virol 2014; 88: 7244-7255.
56. Zelner JL, Lopman BA, Hall AJ, Ballesteros S, Grenfell BT. Linking time-varying symptomatology and intensity of infectiousness to patterns of norovirus transmission. PLoS One 2013; 8: e68413.
57. Graham DY, Jiang X, Tanaka T, Opekun AR, Madore HP, Estes MK. Norwalk virus infection of volunteers: new insights based on improved assays. J Infect Dis 1994; 170: 34-43.
58. Sukhrie FH, Teunis P, Vennema H et al. Nosocomial transmission of norovirus is mainly caused by symptomatic cases. Clin Infect Dis 2012; 54: 931-937.
59. Atmar RL, Opekun AR, Gilger MA et al. Norwalk virus shedding after experimental human infection. Emerg Infect Dis 2008; 14: 1553-1557.
60. Phillips G, Tam CC, Rodrigues LC, Lopman B. Prevalence and characteristics of asymptomatic norovirus infection in the community in England. Epidemiol Infect 2010; 138: 1454-1458.
61. Henke-Gendo C, Harste G, Juergens-Saathoff B, Mattner F, Deppe H, Heim A. New real-time PCR detects prolonged norovirus excretion in highly immunosuppressed patients and children. J Clin Microbiol 2009; 47: 2855-2862.
62. Phillips G, Lopman B, Tam CC, Iturriza-Gomara M, Brown D, Gray J. Diagnosing norovirus-associated infectious intestinal disease using viral load. BMC Infect Dis 2009; 9: 63-71.
63. van Kraaij MG, Dekker AW, Verdonck LF et al. Infectious gastro-enteritis: an uncommon cause of diarrhoea in adult allogeneic and autologous stem cell transplant recipients. Bone Marrow Transplant 2000; 26: 299-303.
64. Florescu DF, Hermsen ED, Kwon JY et al. Is there a role for oral human immunoglobulin in the treatment for norovirus enteritis in immunocompromised patients? Pediatr Transplant 2011; 15: 718-721.
65. Chachu KA, Strong DW, LoBue AD, Wobus CE, Baric RS, Virgin HW. Antibody is critical for the clearance of murine norovirus infection. J Virol 2008; 82: 6610-6617.
66. Greig JD, Lee MB. A review of nosocomial norovirus outbreaks: infection control interventions found effective. Epidemiol Infect 2012; 140: 1151-1160.
67. MacCannell T, Umscheid CA, Agarwal RK, Lee I, Kuntz G, Stevenson KB. Guideline for the prevention and control of norovirus gastroenteritis outbreaks in healthcare settings. Infect Control Hosp Epidemiol 2011; 32: 939-969.
68. Dew K, Keefe V, Small K. 'Choosing' to work when sick: workplace presenteeism. Soc Sci Med 2005; 60: 2273-2282.
69. Atmar RL, Bernstein DI, Harro CD et al. Norovirus vaccine against experimental human Norwalk virus illness. N Engl J Med 2011; 365: 2178-2187.
70. Debbink K, Lindesmith LC, Baric RS. The state of norovirus vaccines. Clin Infect Dis 2014; 58: 1746-1752.
71. Fang H, Tan M, Xia M, Wang L, Jiang X. Norovirus P particle efficiently elicits innate, humoral and cellular immunity. PLoS One 2013; 8: e63269.
72. Danziger-Isakov L, Kumar D. Vaccination in solid organ transplantation. Am J Transpl 2013; 13(suppl 4): 311-317.
73. Rohayem J, Bergmann M, Gebhardt J et al. Antiviral strategies to control calicivirus infections. Antiviral Res 2010; 87: 162-178.